NCT07168096 Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.
| NCT ID | NCT07168096 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación Sociedad Española de Oncologia Médica |
| Condition | Depression |
| Study Type | OBSERVATIONAL |
| Enrollment | 540 participants |
| Start Date | 2024-09-12 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 540 participants in total. It began in 2024-09-12 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To examine the trajectories of anxiety and depression symptoms over the course of oncological disease, and to assess potential predictors-sociodemographic (age, sex, marital status, employment status), clinical (tumor location, stage, treatment type, general health), psychological (coping strategies, quality of life, cognitive difficulties, fear of recurrence), and physical activity-and their association with support needs and utilization of psychosocial services.
Eligibility Criteria
Inclusion Criteria: * Histologically confirmed diagnosis of solid cancer (non-hematologic) at any stage. * Adult age (\>18 years). * Candidate for perioperative systemic antineoplastic treatment or for advanced disease. * Willingness to participate in the study and sign the informed consent form, as appropriate, before initiating any study-specific procedures, in accordance with good clinical practice requirements and local regulations. Exclusion Criteria: * Presence of a pre-existing psychiatric or neurodegenerative disorder that impairs the patient's ability to participate in the study. * Presence of reading and writing difficulties that prevent the patient from completing the assessments. * Receipt of oncological treatment in the past 2 years for another cancer.
Contact & Investigator
Paula Dra. Jiménez Fonseca, MD-PhD
PRINCIPAL INVESTIGATOR
Sociedad Española de Oncología Médica (SEOM)
Frequently Asked Questions
Who can join the NCT07168096 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07168096 currently recruiting?
Yes, NCT07168096 is actively recruiting participants. Contact the research team at palucaji@hotmail.com for enrollment information.
Where is the NCT07168096 trial being conducted?
This trial is being conducted at Santander, Spain, Ciudad Real, Spain, Cuenca, Spain, Alicante, Spain and 11 additional locations.
Who is sponsoring the NCT07168096 clinical trial?
NCT07168096 is sponsored by Fundación Sociedad Española de Oncologia Médica. The principal investigator is Paula Dra. Jiménez Fonseca, MD-PhD at Sociedad Española de Oncología Médica (SEOM). The trial plans to enroll 540 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.